File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how?

TitleDPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how?
Authors
Issue Date2019
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol
Citation
The Lancet Oncology, 2019, v. 20, p. e66 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/267400
ISSN
2017 Impact Factor: 36.421
2015 SCImago Journal Rankings: 13.940

 

DC FieldValueLanguage
dc.contributor.authorLam, KO-
dc.contributor.authorTong, CC-
dc.contributor.authorLee, VHF-
dc.contributor.authorLuk, MY-
dc.contributor.authorLam, CW-
dc.date.accessioned2019-02-18T09:01:14Z-
dc.date.available2019-02-18T09:01:14Z-
dc.date.issued2019-
dc.identifier.citationThe Lancet Oncology, 2019, v. 20, p. e66-
dc.identifier.issn1470-2045-
dc.identifier.urihttp://hdl.handle.net/10722/267400-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/j.lancetoncol-
dc.relation.ispartofThe Lancet Oncology-
dc.titleDPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how?-
dc.typeArticle-
dc.identifier.emailLam, KO: lamkaon@hku.hk-
dc.identifier.emailTong, CC: tccz01@hku.hk-
dc.identifier.emailLee, VHF: vhflee@hku.hk-
dc.identifier.emailLuk, MY: myluk@hkucc.hku.hk-
dc.identifier.emailLam, CW: ching-wanlam@pathology.hku.hk-
dc.identifier.authorityLam, KO=rp01501-
dc.identifier.authorityLee, VHF=rp00264-
dc.identifier.authorityLam, CW=rp00260-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S1470-2045(18)30867-2-
dc.identifier.hkuros296939-
dc.identifier.volume20-
dc.identifier.spagee66-
dc.identifier.epagee66-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats